AstraZeneca PLC (AZNCF)
130.24
+1.04
(+0.80%)
USD |
OTCM |
Nov 14, 16:00
AstraZeneca 1 Year Total Returns (Daily): 5.77% for Nov. 14, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 14, 2024 | 5.77% |
November 13, 2024 | 5.81% |
November 12, 2024 | 5.56% |
November 11, 2024 | 4.23% |
November 08, 2024 | 4.33% |
November 07, 2024 | 3.23% |
November 06, 2024 | 1.94% |
November 05, 2024 | 6.00% |
November 04, 2024 | 15.21% |
November 01, 2024 | 13.50% |
October 31, 2024 | 18.09% |
October 30, 2024 | 23.20% |
October 29, 2024 | 25.88% |
October 28, 2024 | 25.00% |
October 25, 2024 | 20.06% |
October 24, 2024 | 21.89% |
October 23, 2024 | 25.76% |
October 22, 2024 | 24.97% |
October 21, 2024 | 23.56% |
October 18, 2024 | 23.23% |
October 17, 2024 | 15.18% |
October 16, 2024 | 17.04% |
October 15, 2024 | 15.88% |
October 14, 2024 | 11.11% |
October 11, 2024 | 12.38% |
Date | Value |
---|---|
October 10, 2024 | 12.04% |
October 09, 2024 | 13.21% |
October 08, 2024 | 13.77% |
October 07, 2024 | 19.18% |
October 04, 2024 | 16.26% |
October 03, 2024 | 17.43% |
October 02, 2024 | 22.00% |
October 01, 2024 | 17.65% |
September 30, 2024 | 16.85% |
September 27, 2024 | 18.50% |
September 26, 2024 | 16.05% |
September 25, 2024 | 14.33% |
September 24, 2024 | 10.61% |
September 23, 2024 | 14.91% |
September 20, 2024 | 16.25% |
September 19, 2024 | 23.32% |
September 18, 2024 | 27.43% |
September 17, 2024 | 16.58% |
September 16, 2024 | 15.99% |
September 13, 2024 | 24.20% |
September 12, 2024 | 20.83% |
September 11, 2024 | 20.64% |
September 10, 2024 | 20.64% |
September 09, 2024 | 20.52% |
September 06, 2024 | 28.92% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-12.79%
Minimum
Feb 12 2024
55.23%
Maximum
May 21 2020
15.52%
Average
14.23%
Median
1 Year Total Returns (Daily) Benchmarks
Adaptimmune Therapeutics PLC | 62.55% |
Biodexa Pharmaceuticals PLC | -91.74% |
Verona Pharma PLC | 159.4% |
NuCana PLC | -84.20% |
Autolus Therapeutics PLC | -10.11% |